Hypertensive Heart Failure | List of Frontiers open access articles

Review

Published on 17 Aug 2021

Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure

in Cardiovascular Imaging

Viktoria Balogh
Mark G. MacAskill
Patrick W. F. Hadoke
Gillian A. Gray
Adriana A. S. Tavares

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.719031

5,929 views
12 citations

Review

Published on 27 Feb 2025

The various roles of TREM2 in cardiovascular disease

in Inflammation

Shuai Wang
Chenghui Cao
Daoquan Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1462508

11,016 views
3 citations

Original Research

Published on 03 Sep 2020

Endogenous CCN5 Participates in Angiotensin II/TGF-β1 Networking of Cardiac Fibrosis in High Angiotensin II-Induced Hypertensive Heart Failure

in Cardiovascular and Smooth Muscle Pharmacology

Anan Huang
Huihui Li
Chao Zeng
Wanli Chen
Liping Wei
Yue Liu
Xin Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01235

5,396 views
22 citations

Original Research

Published on 09 Mar 2022

An Effective Sodium-Dependent Glucose Transporter 2 Inhibition, Canagliflozin, Prevents Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats

in Cardiovascular and Smooth Muscle Pharmacology

Lili He
Sai Ma
Qingjuan Zuo
Guorui Zhang
Zhongli Wang
Tingting Zhang
Jianlong Zhai
Yifang Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.856386

6,982 views
24 citations

Original Research

Published on 21 Feb 2018

In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction

in Cardiovascular Genetics and Systems Medicine

Raffaele Altara
Fouad A. Zouein
Rita Dias Brandão
Saeed N. Bajestani
Alessandro Cataliotti
George W. Booz

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2018.00011

10,305 views
9 citations

Original Research

Published on 27 Nov 2025

Fractal analysis of left ventricular trabeculae in hypertensive patients with heart failure: a 3.0 T cardiac magnetic resonance study

in Cardiovascular Imaging

Yunxia Xie
Zhenyi Zhao
Kun Deng
Haibo Ren
Sisi Yu
Ziyan Feng
Jiahui Zhang
Hui Liu
Lianggeng Gong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1697453

845 views

Original Research

Published on 08 Dec 2021

U-Shaped Association Between Serum Uric Acid Level and Hypertensive Heart Failure: A Genetic Matching Case-Control Study

in Heart Failure and Transplantation

Hongxuan Xu
Quan Wang
Yunqing Liu
Lingbing Meng
Huanyu Long
Li Wang
Deping Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.708581

3,145 views
4 citations

Original Research

Published on 08 Apr 2020

Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease

in Experimental Pharmacology and Drug Discovery

Daniel P. Zimmer
Courtney M. Shea
Jenny V. Tobin
Boris Tchernychev
Peter Germano
Kristie Sykes
Ali R. Banijamali
Sarah Jacobson
Sylvie G. Bernier
Renee Sarno

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00419

10,865 views
33 citations

Articles

Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure

The various roles of TREM2 in cardiovascular disease

Endogenous CCN5 Participates in Angiotensin II/TGF-β1 Networking of Cardiac Fibrosis in High Angiotensin II-Induced Hypertensive Heart Failure

An Effective Sodium-Dependent Glucose Transporter 2 Inhibition, Canagliflozin, Prevents Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats

In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction

Fractal analysis of left ventricular trabeculae in hypertensive patients with heart failure: a 3.0 T cardiac magnetic resonance study

U-Shaped Association Between Serum Uric Acid Level and Hypertensive Heart Failure: A Genetic Matching Case-Control Study

Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease